News

The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about ...
FDA Commissioner Marty Makary reportedly initiated a brief request last week to decline approval of a rare disease drug ...
Nestle said Wednesday it will eliminate artificial colors from its U.S. food and beverages by the middle of 2026. It’s the ...
Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...
All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...
And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...
But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...
FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.
MedPage Today on MSN1dOpinion
How Fast Is Too Fast for FDA Drug Review?
In announcing his new Commissioner's National Priority Voucher (CNPV) program, FDA Commissioner Marty Makary, MD, MPH, ...
Curay, the FDA’s acting top drug regulator, is stepping down from her post after serving at the agency for more than eight ...
FDA Commissioner Marty Makary said that one of his key priorities is to modernize the agency by streamlining the drug review ...
And more health news stories you need to start your week.